Viral vector demand still exceeds capacity, according to analysts who say biopharma firms and CDMOs need new facilities and more efficient production processes. Industry concerns about vector supplies ...
An engineering test model of the Vector-R rocket at Pad 0B of the Mid-Atlantic Regional Spaceport at Wallops Island, Virginia. Credit: Vector Updated 12:45 a.m. Eastern Aug. 10 with company statement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback